Global Travelers Vaccines Market Research Report 2021
1 Travelers Vaccines Market Overview
- 1.1 Product Overview and Scope of Travelers Vaccines
- 1.2 Travelers Vaccines Segment by Type
- 1.2.1 Global Travelers Vaccines Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 Meningococcal Vaccine
- 1.2.3 Japanese Encephalitis Vaccine
- 1.2.4 Yellow Fever Vaccine
- 1.2.5 Hepatitis Vaccine
- 1.2.6 Cholera Vaccine
- 1.2.7 Other
- 1.3 Travelers Vaccines Segment by End Users
- 1.3.1 Global Travelers Vaccines Sales Comparison by End Users: (2021-2027)
- 1.3.2 Tourists
- 1.3.3 Students
- 1.3.4 Workers
- 1.3.5 Others
- 1.4 Global Travelers Vaccines Market Size Estimates and Forecasts
- 1.4.1 Global Travelers Vaccines Revenue 2016-2027
- 1.4.2 Global Travelers Vaccines Sales 2016-2027
- 1.4.3 Travelers Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Travelers Vaccines Market Competition by Manufacturers
- 2.1 Global Travelers Vaccines Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Travelers Vaccines Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Travelers Vaccines Manufacturing Sites, Area Served, Product Type
- 2.5 Travelers Vaccines Market Competitive Situation and Trends
- 2.5.1 Travelers Vaccines Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Travelers Vaccines Players Market Share by Revenue
- 2.5.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travelers Vaccines Retrospective Market Scenario by Region
- 3.1 Global Travelers Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.2 Global Travelers Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.3 North America Travelers Vaccines Market Facts & Figures by Country
- 3.3.1 North America Travelers Vaccines Sales by Country
- 3.3.2 North America Travelers Vaccines Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Travelers Vaccines Market Facts & Figures by Country
- 3.4.1 Europe Travelers Vaccines Sales by Country
- 3.4.2 Europe Travelers Vaccines Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Travelers Vaccines Market Facts & Figures by Region
- 3.5.1 Asia Pacific Travelers Vaccines Sales by Region
- 3.5.2 Asia Pacific Travelers Vaccines Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Travelers Vaccines Market Facts & Figures by Country
- 3.6.1 Latin America Travelers Vaccines Sales by Country
- 3.6.2 Latin America Travelers Vaccines Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Travelers Vaccines Sales by Country
- 3.7.2 Middle East and Africa Travelers Vaccines Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 U.A.E
4 Global Travelers Vaccines Historic Market Analysis by Type
- 4.1 Global Travelers Vaccines Sales Market Share by Type (2016-2021)
- 4.2 Global Travelers Vaccines Revenue Market Share by Type (2016-2021)
- 4.3 Global Travelers Vaccines Price by Type (2016-2021)
5 Global Travelers Vaccines Historic Market Analysis by End Users
- 5.1 Global Travelers Vaccines Sales Market Share by End Users (2016-2021)
- 5.2 Global Travelers Vaccines Revenue Market Share by End Users (2016-2021)
- 5.3 Global Travelers Vaccines Price by End Users (2016-2021)
6 Key Companies Profiled
- 6.1 GlaxoSmithKline
- 6.1.1 GlaxoSmithKline Corporation Information
- 6.1.2 GlaxoSmithKline Description and Business Overview
- 6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
- 6.1.5 GlaxoSmithKline Recent Developments/Updates
- 6.2 Sanofi Pasteur
- 6.2.1 Sanofi Pasteur Corporation Information
- 6.2.2 Sanofi Pasteur Description and Business Overview
- 6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
- 6.2.5 Sanofi Pasteur Recent Developments/Updates
- 6.3 Merck
- 6.3.1 Merck Corporation Information
- 6.3.2 Merck Description and Business Overview
- 6.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 Merck Travelers Vaccines Product Portfolio
- 6.3.5 Merck Recent Developments/Updates
- 6.4 Pfizer
- 6.4.1 Pfizer Corporation Information
- 6.4.2 Pfizer Description and Business Overview
- 6.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Pfizer Travelers Vaccines Product Portfolio
- 6.4.5 Pfizer Recent Developments/Updates
- 6.5 CNBG
- 6.5.1 CNBG Corporation Information
- 6.5.2 CNBG Description and Business Overview
- 6.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 CNBG Travelers Vaccines Product Portfolio
- 6.5.5 CNBG Recent Developments/Updates
- 6.6 Sanofi Pasteur MSD
- 6.6.1 Sanofi Pasteur MSD Corporation Information
- 6.6.2 Sanofi Pasteur MSD Description and Business Overview
- 6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
- 6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
- 6.7 Serum Institute of India
- 6.6.1 Serum Institute of India Corporation Information
- 6.6.2 Serum Institute of India Description and Business Overview
- 6.6.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Serum Institute of India Travelers Vaccines Product Portfolio
- 6.7.5 Serum Institute of India Recent Developments/Updates
- 6.8 Biokangtai
- 6.8.1 Biokangtai Corporation Information
- 6.8.2 Biokangtai Description and Business Overview
- 6.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
- 6.8.4 Biokangtai Travelers Vaccines Product Portfolio
- 6.8.5 Biokangtai Recent Developments/Updates
7 Travelers Vaccines Manufacturing Cost Analysis
- 7.1 Travelers Vaccines Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Travelers Vaccines
- 7.4 Travelers Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Travelers Vaccines Distributors List
- 8.3 Travelers Vaccines Customers
9 Travelers Vaccines Market Dynamics
- 9.1 Travelers Vaccines Industry Trends
- 9.2 Travelers Vaccines Growth Drivers
- 9.3 Travelers Vaccines Market Challenges
- 9.4 Travelers Vaccines Market Restraints
10 Global Market Forecast
- 10.1 Travelers Vaccines Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Travelers Vaccines by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Travelers Vaccines by Type (2022-2027)
- 10.2 Travelers Vaccines Market Estimates and Projections by End Users
- 10.2.1 Global Forecasted Sales of Travelers Vaccines by End Users (2022-2027)
- 10.2.2 Global Forecasted Revenue of Travelers Vaccines by End Users (2022-2027)
- 10.3 Travelers Vaccines Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Travelers Vaccines by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Travelers Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by End Users
Tourists
Students
Workers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai